Navigation Links
Transcept Announces Plans to Reduce Expenses by Decreasing Staff Following Recent Completion of Purdue U.S. License and Collaboration Agreement
Date:8/18/2009

RICHMOND, Calif., Aug. 18 /PRNewswire-FirstCall/ -- Transcept Pharmaceuticals, Inc. (Nasdaq: TSPT) today announced plans to reduce operating expenses by eliminating certain staff positions following its recently announced License and Collaboration Agreement with Purdue Pharmaceutical Products to commercialize Intermezzo((R) )(zolpidem tartrate sublingual tablet) in the United States.

Glenn A. Oclassen, President and Chief Executive Officer commented, "Our overall staffing needs have been modified by the development of Intermezzo((R)) to the point of NDA submission and our recently announced agreement with Purdue Pharmaceuticals to commercialize Intermezzo((R)) in the United States. Should Purdue elect to continue with our license and collaboration agreement after an FDA approval of Intermezzo((R)), Purdue will be responsible for the effort and costs associated with the commercialization of the product in the United States, including sales and marketing efforts in the primary care market, post-approval regulatory affairs activities and commitments, and product manufacturing. We are therefore phasing out certain positions that have been rendered non-essential by our development success to date and our agreement with Purdue. We believe that this important cost containment step is consistent with our long standing principle of conservative cash management."

Mr. Oclassen continued, "The streamlined team we will now have in place will be intently focused on seeking FDA approval for Intermezzo((R)), the worldwide commercialization of Intermezzo((R)), and the evaluation of potential additions to our product pipeline. The decision to make this approximately 30 percent reduction in our workforce was a difficult one for all of us and was ma
'/>"/>

SOURCE Transcept Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Transcept Pharmaceuticals Reports Second Quarter 2009 Financial Results
2. Transcept Pharmaceuticals to Report Second Quarter 2009 Results
3. Transcept Pharmaceuticals to Hold Conference Call on Agreement with Purdue Pharmaceutical Products L.P. to Commercialize Intermezzo(R) in the United States
4. Transcept Pharmaceuticals to Present at BMO Capital Markets Healthcare Conference on August 5, 2009
5. Transcept Pharmaceuticals Announces Expected FDA Extension of Regulatory Review Period for Intermezzo(R)
6. Transcept Pharmaceuticals to Present at Needham Life Sciences Conference on June 10, 2009
7. Transcept Pharmaceuticals Presents Data from Studies of Two Product Candidates at Annual Meeting of the American Psychiatric Association
8. Transcept Pharmaceuticals Reports First Quarter 2009 Financial Results
9. Transcept Pharmaceuticals Appoints Joseph T. Kennedy as General Counsel
10. Transcept Pharmaceuticals Reports Fourth Quarter and Year End 2008 Financial Results
11. Transcept Pharmaceuticals to Report Fourth Quarter 2008 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)... ... July 01, 2015 , ... These listings ... case management, placement, sober companionship and delivery to wilderness therapy or treatment facilities. ... and transporting clients with anxiety, ADHD, autism spectrum disorders, eating disorders, severe learning ...
(Date:7/1/2015)... ... July 01, 2015 , ... RF ... solutions, has partnered with WIU Crossroads School in safeguarding its staff and students ... (Alternative Education for Disruptive Youth) environment of Crossroads School heightens the potential for ...
(Date:7/1/2015)... ... July 01, 2015 , ... Professional Physical Therapy (“Professional”), ... and New Jersey, acquired South Bay Sports & Physical Therapy ("South Bay"), located ... this most recent member of the Professional family, patients can expect an expert ...
(Date:6/30/2015)... (PRWEB) , ... June 30, 2015 , ... ... year, it has proven its continuing growth as a Master Franchisor. 1Heart Caregiver ... 17th, the Simi Valley Chamber of Commerce Ambassadors headed by Keith Mashburn, Pam ...
(Date:6/30/2015)... ... June 30, 2015 , ... America is in a health ... autism, dementia, auto-immune deficiencies, or obesity. Why? , The answer is simple and is ... America’s Leading Stress Expert, has successfully treated over one million patients and, for the ...
Breaking Medicine News(10 mins):Health News:All Kinds of Therapy – Announces New Partnership Feature, Therapeutic Experts 2Health News:WIU Crossroads School Chooses Help Alert Mobile Staff Duress Pendants from RF Technologies to Safeguard Staff and Students, De-escalate Altercations 2Health News:WIU Crossroads School Chooses Help Alert Mobile Staff Duress Pendants from RF Technologies to Safeguard Staff and Students, De-escalate Altercations 3Health News:Professional Physical Therapy Acquires Copiague’s South Bay Sports & Physical Therapy, P.C. 2Health News:1Heart Caregiver Services® Simi Valley Grand Opening 2Health News:1Heart Caregiver Services® Simi Valley Grand Opening 3Health News:1Heart Caregiver Services® Simi Valley Grand Opening 4Health News:12 Easy-To-Follow Steps to Transform Body, Mind and Spirit 2
... New Non-Steroidal Skin Treatment to Treat All ... with Steroids, BARRINGTON, Ill., Oct. 19 Steroids have ... abuse. There must be reasons why,people use steroid products on ... largest organ of the human body, and it needs to ...
... 19 Uroplasty, Inc. (Amex:,UPI) announced today that ... Securities and Exchange Commission in anticipation of a ... of its,common stock. Craig-Hallum Capital Group and ... connection with this proposed public offering.,A copy of ...
... Scans, Oct 26 & 27, as Part of Clinical Study., CHICAGO, ... Stage III or Stage IV ... at no charge as part of a clinical trial. ... cancer that tests positive for a protein called human ...
... Holdings, Inc. and its,operating subsidiary, US Oncology, Inc., ... November 8, 2007. A conference call and ... EST, for the company,s bondholders following the distribution ... US Oncology,s management,team will discuss the financial results. ...
... Oct. 18 West Pharmaceutical,Services, Inc. (NYSE: ... announcement that it has decided to discontinue marketing ... to the,Company,s customer, Nektar Therapeutics, Inc. The Company,s ... the Exubera inhalation device for Nektar. "We ...
... cancer patients with the poorest prognosis -- those with a ... may survive longer with a drug that chokes off ... by researchers at Dukes Preston Robert Tisch Brain Tumor Center, ... and a standard chemotherapy agent, may increase the amount of ...
Cached Medicine News:Health News:Steroids Are Abused for Skin, Not Just Muscles 2Health News:Uroplasty, Inc. Announces Filing of Registration Statement for Offering of Common Stock 2Health News:Uroplasty, Inc. Announces Filing of Registration Statement for Offering of Common Stock 3Health News:Brain Screenings Offered to Breast Cancer Patients During Breast Cancer Awareness Month 2Health News:West Pharmaceutical Services Issues Statement on Exubera 2Health News:West Pharmaceutical Services Issues Statement on Exubera 3Health News:West Pharmaceutical Services Issues Statement on Exubera 4Health News:Drug combination might offer hope for patients deadly brain tumors 2
(Date:6/30/2015)... new report released today from the Institute of Medicine ... training opportunities to reduce barriers to the provision of ... of CPR and AED use by bystanders remain less ... even though evidence indicates that its use ... strongly supports the IOM,s recommendation to encourage training through ...
(Date:6/30/2015)... -- Research and Markets( http://www.researchandmarkets.com/research/54fkmt/global_array ... "Global Array Instruments Market 2015-2019" report to ... market to grow at a CAGR of 12.48 ... array instruments market can be divided into three ... tissue microarrays and cell microarrays. This report covers ...
(Date:6/30/2015)...  Today, the National Mobility Equipment Dealers Association (NMEDA) ... Awareness Month Local Heroes Contest on National TV. The ... received 1.3 million votes. The sponsors for the wheelchair ... , and Valley Honda Dealers , with the ... Mobility International (VMI) and ElDorado Mobility .  ...
Breaking Medicine Technology:New Recommendations in Cardiac Arrest Protocol Advocate for Increased CPR and AED Training to Improve U.S. Survival Rates 2New Recommendations in Cardiac Arrest Protocol Advocate for Increased CPR and AED Training to Improve U.S. Survival Rates 3New Recommendations in Cardiac Arrest Protocol Advocate for Increased CPR and AED Training to Improve U.S. Survival Rates 4Global Array Instruments Market 2015-2019 - Advances in Personalized Medicines with Affymetrix, Agilent Technologies & Illumina Dominating 2NMEDA Announces National Contest Winners 2NMEDA Announces National Contest Winners 3
... The new Finnpipette Focus ... specifically to combine ergonomics with ... interchangeable handle plate offers a ... sizes. The new shorter tip ...
... The Eppendorf Reference Series 2000 Pipette ... smooth stroke, a compact and robust design, ... button is used to operate the measuring ... the tip. Product features:Eppendorf "pipette/tip" system ensures ...
Pipetman F is a fixed-volume, air-displacement pipette. Thirteen robust models cover a large volume range from 2 L to 1000 L, with Gilsons legendary accuracy and precision....
... The Eppendorf Reference Series 2000 Pipette ... smooth stroke, a compact and robust design, ... button is used to operate the measuring ... the tip. Product features:Eppendorf "pipette/tip" system ensures ...
Medicine Products: